EMERGENT METALS CORP (EMR.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:EMR - CA29103R1055 - Common Stock

0.105 CAD

+0.02 (+31.25%)

Last: 1/26/2026, 7:00:00 PM

Fundamental Rating

Overall EMR gets a fundamental rating of 1 out of 10. We evaluated EMR against 820 industry peers in the Metals & Mining industry. EMR has a bad profitability rating. Also its financial health evaluation is rather negative. EMR has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EMR has reported negative net income.
In the past year EMR has reported a negative cash flow from operations.
EMR had negative earnings in each of the past 5 years.
In the past 5 years EMR always reported negative operating cash flow.

1.2 Ratios

EMR has a better Return On Assets (-6.93%) than 66.22% of its industry peers.
Looking at the Return On Equity, with a value of -17.18%, EMR is in line with its industry, outperforming 59.39% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-6.93%
ROE	-17.18%
ROIC	N/A

ROA(3y)-29.32%

ROA(5y)-22.86%

ROE(3y)-110.25%

ROE(5y)-75.07%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EMR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EMR has more shares outstanding than it did 1 year ago.
EMR has more shares outstanding than it did 5 years ago.
EMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -27.52, we must say that EMR is in the distress zone and has some risk of bankruptcy.
EMR's Altman-Z score of -27.52 is on the low side compared to the rest of the industry. EMR is outperformed by 76.46% of its industry peers.
EMR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
EMR has a Debt to Equity ratio of 0.02. This is comparable to the rest of the industry: EMR outperforms 44.02% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	-27.52

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.22 indicates that EMR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.22, EMR is doing worse than 76.71% of the companies in the same industry.
A Quick Ratio of 0.22 indicates that EMR may have some problems paying its short term obligations.
With a Quick ratio value of 0.22, EMR is not doing good in the industry: 75.98% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.22
Quick Ratio	0.22

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.02%, which is quite impressive.

EPS 1Y (TTM)89.02%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.